CapsoVision CV
NASDAQ CV
$6.52 +0.15 (+2.34%)
As of: Sep 10, 2026 · 3:59 PM EDT

CapsoVision (CV) Asset Utilization Ratio (2025 - 2026)

CapsoVision's (CV) quarterly Asset Utilization Ratio came in at 0.78 in Q2 2026, down 17.78% year-over-year from 0.95 in Q2 2025, and up 20.91% quarter-over-quarter from 0.65 in Q4 2025.

Analysis

CapsoVision (CV) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

CapsoVision has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.78 for Q2 2026.

  • In Q2 2026, Asset Utilization Ratio fell 17.78% year-over-year to 0.78; the TTM figure through Jun 2026 stood at 0.78 (down 17.78% YoY), while the FY2025 annual figure was 0.78, changed N/A from the prior year.
  • Asset Utilization Ratio came in at 0.78 for Q2 2026 at CapsoVision, up from 0.65 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.95 in Q2 2025 to a low of 0.65 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 GE HealthCare Technologies 29.10 Bn 26.99 Bn 2.18 Bn 0.57
2 Lantheus Holdings 6.54 Bn 5.95 Bn 241.86 Mn 0.65
3 Heartflow 3.94 Bn 3.56 Bn 53.19 Mn 0.58
4 Neogen 2.57 Bn 2.38 Bn 107.80 Mn 0.26
5 Butterfly Network 1.86 Bn 1.74 Bn 23.29 Mn 0.39
6 Ceribell 889.95 Mn 760.69 Mn 25.94 Mn 0.59
7 QuidelOrtho 828.82 Mn 705.42 Mn - -
8 Varex Imaging 778.01 Mn 678.81 Mn 76.70 Mn 0.79
9 Prenetics Global 332.61 Mn 273.56 Mn 30.20 Mn 0.85
10 CapsoVision 329.59 Mn 320.51 Mn 1.87 Mn 0.78
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.78
Dec 31, 2025 0.65
Sep 30, 2025 0.75
Jun 30, 2025 0.95